ORMP Oramed Pharmaceuticals Inc

Price (delayed)

$4.84

Market cap

$198.08M

P/E Ratio

1.83

Dividend/share

$0.25

EPS

$2.65

Enterprise value

$185.64M

?
Relative Growth: Rel. Growth: 38
Relative Strength: Rel. Strength: 88
Relative Valuation: Rel. Valuation: 93
Relative Profitability: Rel. Profitability: 62

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and ...

Highlights
The EPS has surged by 73% since the previous quarter
The net income has soared by 72% QoQ
ORMP's debt has soared by 153% YoY but it is down by 8% QoQ
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Key stats

What are the main financial stats of ORMP

ORMP stock price

How has the Oramed Pharmaceuticals stock price performed over time
Intraday
4.31%
1 week
16.07%
1 month
21.91%
1 year
115.11%
YTD
69.82%
QTD
42.35%

Financial performance

How have Oramed Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.25M
Net income
$110M
Gross margin
N/A
Net margin
N/A
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
The net income has soared by 72% QoQ
The operating income is up by 6% since the previous quarter

Price vs fundamentals

How does ORMP's price correlate with its fundamentals

Growth

What is Oramed Pharmaceuticals's growth rate over time

Valuation

What is Oramed Pharmaceuticals stock price valuation
P/E
1.83
P/B
0.82
P/S
N/A
EV/EBIT
1.59
EV/EBITDA
1.59
EV/Sales
N/A
The EPS has surged by 73% since the previous quarter
The equity has soared by 69% YoY and by 19% from the previous quarter
The P/B is 39% less than the 5-year quarterly average of 1.3 but 32% more than the last 4 quarters average of 0.6
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Oramed Pharmaceuticals business performance
The ROE has soared by 51% from the previous quarter
The ROA is up by 48% since the previous quarter
The company's return on invested capital rose by 16% QoQ

Dividends

What is ORMP's dividend history
DPS
$0.25
Dividend yield
5.17%
Payout ratio
9.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Oramed Pharmaceuticals financials performed over time
The total assets has soared by 82% YoY and by 16% from the previous quarter
Oramed Pharmaceuticals's quick ratio has shrunk by 74% YoY and by 9% QoQ
ORMP's debt is 100% lower than its equity
ORMP's debt has soared by 153% YoY but it is down by 8% QoQ
The equity has soared by 69% YoY and by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.